ClinicalTrials.Veeva

Menu

Non-invasive Measures of Distal Lung Disease in Asthmatics

Teva Pharmaceuticals logo

Teva Pharmaceuticals

Status and phase

Completed
Phase 4

Conditions

Asthma

Treatments

Drug: QVAR
Drug: Servent Diskus
Drug: Advair

Study type

Interventional

Funder types

Industry

Identifiers

NCT00250341
IXR-403-4-196

Details and patient eligibility

About

This is a Phase 4, single center study conducted in mild-to moderate asthmatics.

Full description

The study consists of 3 phases. There are 7 study visits.

Enrollment

34 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18-65 years old
  • Currently using SABA prn or a low-to-moderate persistent asthma

Exclusion criteria

  • Tobacco use within 1 year or >= 5 pack years

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

34 participants in 2 patient groups

Advair
Active Comparator group
Treatment:
Drug: Advair
QVAR
Experimental group
Treatment:
Drug: Servent Diskus
Drug: QVAR

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems